Cutaneous malignant melanoma in women and the role of oral contraceptives
โ Scribed by Gefeller; Hassan; Wille
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 276 KB
- Volume
- 138
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
โฆ Synopsis
The role of oral contraceptives (OC) in the aetiology of cutaneous malignant melanoma (CMM) has been controversially discussed over the last two decades. In an extensive literature search we identified 18 case-control studies, published between 1977 and 1996, offering information on this relationship. Using a meta-analytical approach we combined the study-specific risk estimates and derived a summary odds ratio of 0.95 (95% confidence interval: 0.87-1.04). Based on the data of 3796 cases and 9442 controls, we thus found no evidence for an aetiological role of OC use in the development of CMM.
๐ SIMILAR VOLUMES
Diagnostic accuracy for melanoma was determined in a dedicated pigmented lesion clinic. We assessed the impact of duration of experience in dermatology and also the relationship between tumour thickness and accuracy of clinical diagnosis. We reviewed the histopathology request forms and reports for
Background. Excessive risk of cutaneous melanoma as a second cancer has been associated with benign or malignant tumors of the nervous system. Cutaneous melanoma and nervous system tumors may independently aggregate in families. There are, however, no previous reports of increased likelihood of tumo